Status:
COMPLETED
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Delirium
Confusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To improve the safety of diagnosis and therapy for a set of conditions and undifferentiated symptoms for hospitalized patients, the investigators will employ a set of methods and tools from the discip...
Detailed Description
The goal of this study is to improve the safety of diagnosis and therapy for a set of conditions and undifferentiated symptoms for hospitalized patients. The investigators will employ a set of methods...
Eligibility Criteria
Inclusion
- Age 18 or older
- Adult patients admitted to General Medicine Services at Brigham and Women's Hospital during the 21-months study data collection period
- English speakers
- Patients who were diagnosed with any of the following conditions and symptoms upon admission:
- Abdominal pain
- Altered mental status/ delirium / confusion
- Asthma / chronic obstructive pulmonary disease (COPD)
- Cellulitis / soft tissue infection
- Chest pain
- Cough
- Deep vein thrombosis / pulmonary embolism / venous thromboembolism
- Dyspnea / short of breath
- Failure to thrive
- Pneumonia
- Protein-calorie malnutrition
- Sepsis
- Other conditions typical of general medicine patients
Exclusion
- Not pregnant women, prisoners and institutionalized individuals
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04393909
Start Date
July 1 2019
End Date
December 30 2021
Last Update
July 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02120